The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
The Role of Energy Metabolism Dysfunction and Oxidative Stress in Schizophrenia Revealed by Proteomics
Abstract
Schizophrenia is a psychiatric illness that affects approximately 30 million people worldwide. Converging lines of evidence suggest that mitochondrial function may be compromised in this disorder, and this can lead to perturbations in calcium buffering, oxidative phosphorylation, increased production of reactive oxygen species, and apoptotic factors, which can, in turn, affect neuronal processes such as neurotransmitter synthesis and synaptic plasticity. Proteomics studies in brain and peripheral tissues of schizophrenia patients have provided considerable evidence and identified biomarker fingerprints corresponding to such pathways. Here we review the results of these studies with a focus on the biomarker pattern depicting alterations in energy metabolism and oxidative stress in this debilitating illness. Antioxid. Redox Signal. 15, 2067–2079.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“GSH levels have been shown to be lower in chronic schizophrenia, as measured in the CSF and post-mortem brain, and by MRS-based in vivo imaging 41,42 and the GSH system enzymes glutathione peroxidase (GPX) and glutathione reductase (GR) are also dysregulated 36 .”
From Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis (2016) · cites this paper as [42]
Citations
Cites
KEGG: Kyoto Encyclopedia of Genes and Genomes
Kanehisa, M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.27 · Cited by 37,077
KEGG: Kyoto Encyclopedia of Genes and Genomes
Ogata, H., Goto, S., Sato, K., Fujibuchi, W., Bono, H., & Kanehisa, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.29 · Cited by 31,232
Hayes, J. D., Flanagan, J. U., & Jowsey, I. R. (2004) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095857 · Cited by 3,565
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
Howes, O. D., & Kapur, S. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp006 · Cited by 2,693
Direct analysis of protein complexes using mass spectrometry
Link, A. J., Eng, J. K., Schieltz, D. M., Carmack, E., Mize, G. J., Morris, D. R., Garvik, B. M., & Yates, J. R. (1999) · Nature Biotechnology · doi:10.1038/10890 · Cited by 2,218
The neuropathology of schizophrenia
Harrison, P. J. (1999) · Brain · doi:10.1093/brain/122.4.593 · Cited by 1,677
Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology
Gygi, S. P., Corthals, G. L., Zhang, Y., Rochon, Y. P., & Aebersold, R. H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160270797 · Cited by 1,311
Prabakaran, S., SWATTON, J. E., Ryan, M. M., Huffaker, S. J., Huang, J.-J., Griffin, J. L., Wayland, M. T., Freeman, T., Dudbridge, F., Lilley, K. S., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001511 · Cited by 985
Self-citationProgress with gene‐product mapping of the Mollicutes: Mycoplasma genitalium
Wasinger, V. C., Cordwell, S. J., Poljak, A., Yan, J. X., Gooley, A. A., Wilkins, M. R., Duncan, M. W., Harris, R. J., Williams, K. L., & Humphery‐Smith, I. (1995) · Electrophoresis · doi:10.1002/elps.11501601185 · Cited by 962
Flagged first, then by citations
Research works printed but not linked: 4
- Gulidova GP, , Polianskaia NP. Possible reasons for changes in energy metabolism in brain mitochondria under the influence of schizophrenic patients' serum. Zh Nevropatol Psikhiatr Im S S Korsakova, 73:110–116. 1973.
- Heidema CR. Bloedsuikerbepalingen bij psyebiatrische en neurologische patienten. Dissertation, Utrecht, 1918.
- Kuznetsova NI, , ZykovIu V, , Sorokina IN. Reaction of anticerebral antibodies in the sera of patients with neuro-psychic disorders to mitochondria and other fractions of brain tissue extract. Bull Eksp Biol Med., 62:47–50. 1966.
- 10.1016/J.psychires.2010.04.014 · DOI
Cited by
Sorted by citations
Items 101–134 of 134
Ayesha, K., Zahid, S., Hasan, B., Asif, A. R., & Ahmed, N. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08431-3 · Cited by 4
Groleau, S. E., Lubarda, J., Thomas, N., Ferro, M. A., Pristupa, Z. B., Mishra, R. K., & Gabriele, J. P. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.10.034 · Cited by 4
Antunes, A. S. L. M., Reis‐de‐Oliveira, G., & Martins‐de‐Souza, D. (2024) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-024-01842-8 · Cited by 5
Self-citationLin, C., Hu, Q., Dong, J., Wei, Z., Li, J., & Chen, Z. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.998709 · Cited by 3
IUPHAR review: Drug repurposing in Schizophrenia – An updated review of clinical trials
Zaki, J. K., Tomasik, J., & Bahn, S. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107633 · Cited by 3
Self-citationProteomic Biomarkers for Psychiatric Disorders: A Progress Update
Martins‐de‐Souza, D., & Turck, C. W. (2012) · Biomarkers in Medicine · doi:10.2217/bmm.12.6 · Cited by 3
Self-citationKnown and Unexplored Post-Translational Modification Pathways in Schizophrenia
Smith, B. J., & Carregari, V. C. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-97182-3_6 · Cited by 3
Protein Carbonylation in Brains of Subjects with Selected Neurodegenerative Disorders
Reed, T. T., & Butterfield, D. A. (2017) · Wiley eBooks · doi:10.1002/9781119374947.ch8 · Cited by 3
Moises, H. W., Hess, M., & Binder, H. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/158436 · Cited by 2
Hosseini, L., Abolhasanpour, N., Seyedaghamiri, F., Hassanzadeh, P., Shahabi, P., Mafikandi, V., Kalejahi, P., Rajabi, M., Shokri, Z., & Fakhari, A. (2025) · Molecular Brain · doi:10.1186/s13041-025-01255-1 · Cited by 2
Nutritional Management of Schizophrenia: Gut-Brain Axis Mechanisms and Dietary Interventions
Vakili, O., Motamed, M., Taghizadeh, M., & Khatami, S. H. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05751-w · Cited by 2
Explorando o componente inflamatório da esquizofrenia
Rahmoune, H., Harris, W., Guest, P. C., & Bahn, S. (2012) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/s0101-60832012005000003 · Cited by 2
Self-citationFarrelly, L. A., Föcking, M., & Cotter, D. (2014) · Advances in biological psychiatry · doi:10.1159/000358028 · Cited by 2
de Souza, T. P., Rodríguez-Vega, A., Dutra-Tavares, A. C., Semeão, K. A., Filgueiras, C. C., Ribeiro‐Carvalho, A., Manhães, A. C., & Abreu‐Villaça, Y. (2025) · Biomedicines · doi:10.3390/biomedicines13040901 · Cited by 1
Proteomics in the Diagnosis of Inborn Encephalopathies of Unknown Origin: A Myth or Reality
Kupniewska, A., Szymańska, K., & Demkow, U. A. (2017) · Advances in experimental medicine and biology · doi:10.1007/5584_2017_104 · Cited by 1
Proteomic Characterization of the Brain and Cerebrospinal Fluid of Schizophrenia Patients
Café-Mendes, C. C., Gattaz, W. F., Schmitt, A., Britto, L. R. G., & Martins‐de‐Souza, D. (2014) · Advances in biological psychiatry · doi:10.1159/000358021
Self-citationBlood-based Biomarkers for Personalised Medicine Applications in Schizophrenia
Tomasik, J. (2014) · EUR Research Repository (Erasmus University Rotterdam)
Chalkiadaki, K., Velli, A., Kyriazidis, E., Stavroulaki, V., Vouvoutsis, V., Chatzaki, E., Aivaliotis, M., & Sidiropoulou, K. (2018) · bioRxiv · doi:10.1101/295741 · Cited by 3
Proteômica da esquizofrenia: busca por biomarcadores em plaquetas
Joaquim, H. P. G. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2018.tde-09042018-095856
Understanding mania in bipolar disorder : perspectives on causation and pathogenesis
Bostock, E. C. S. (2019) · UTAS Research Repository · doi:10.25959/100.00031394
Effects of Antipsychotic Treatment on S100B and Oxidative Stress in Patients with Schizophrenia
Wang, X., Bian, Y., Liu, L., Wu, Y., Yang, F., Li, X., Han, X., Tian, L., Luο, X., Chen, S., et al. (2019) · Global Clinical and Translational Research · doi:10.36316/gcatr.01.0018
Luckhaus, C., Roosterman, D., & Juckel, G. (2020) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/a-0832-8766
Petervary, N. (2021) · NCSU Libraries Repository (North Carolina State University Libraries)
Mitochondrial abnormalities in psychological disorders
Mousavi, T., & Abdollahi, M. R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822416-8.00013-0
O'Brien, J. T., Jalilvand, S. P., Suji, N. A., Phensy, A. J., Jupelly, R. K., Mwirigi, J. M., Elahi, H., Price, T. J., & Kroener, S. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.19.541499
Costa, J. V. C. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.46.2022.tde-07112023-151721
Tozoğlu, E. Ö., Gürbüzer, N., Özkaya, A. L., & Akyıldırım, S. (2025) · Diagnostics · doi:10.3390/diagnostics15050632
de Oliveira, C. A., Soares, M. V. R., de Pinho, C. S. N., Pinto, J. P., Frota, A. F., Moreira, A. C. D. O., Silva, M. F. S., Batista, T. D. O., Hallak, J. E. C., Sheheryar, S., et al. (2026) · Schizophrenia Research · doi:10.1016/j.schres.2026.04.022
Uranova, N. A., Vikhreva, O. V., & Рахманова, В. И. (2026) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-026-02263-5
Locci, E., Pintori, N., Chighine, A., Kesharwani, R., Serra, M. P., Aloja, E. D., & Luca, M. A. D. (2026) · Toxicology · doi:10.1016/j.tox.2026.154595
Energetic dysregulations in psychotic disorders: Targets for new therapeutics
Anderson, J., Sonntag, K., Le, T. D. V., Shannon, K., Wang, C., Du, F., Chen, X., McPhie, D. L., Öngür, D., Cohen, B. M., et al. (2026) · FEBS Journal · doi:10.1111/febs.70719
de Souza, T. P., Rodríguez-Vega, A., Dutra-Tavares, A. C., Semeão, K. A., Filgueiras, C. C., Ribeiro‐Carvalho, A., Manhães, A. C., & Abreu‐Villaça, Y. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27209328
Metadata
- Authors
- Martins-de-Souza, D., Harris, L. W., Guest, P. C., & Bahn, S.
- Affiliations
- University of Cambridge
- University of Cambridge (GB)
- Venue
- Antioxidants & Redox Signaling
- Publisher
- SAGE Publications
- Published
- 2011-10
- Volume
- 15
- Issue
- 7
- Pages
- 2067-2079
- ISSN
- 1523-0864 (ISSN-L)
- 1557-7716
- OpenAlex
- W2017966444
- Cited by
- 134
- References
- 91
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 2 · 2023: 8 · 2022: 12 · 2021: 5 · 2020: 8 · 2019: 8 · 2018: 8 · 2017: 10 · 2016: 12 · 2015: 8 · 2014: 12 · 2013: 7 · 2012: 13
- FWCI
- 1.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Antioxidants and Redox Signaling (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Stanley Medical Research Institute
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Keywords
- schizophrenia, oxidative stress, mitochondrial dysfunction, reactive oxygen species, apoptosis, biomarkers, proteomics, brain, peripheral tissues, calcium buffering, oxidative phosphorylation, synaptic plasticity
- MeSH terms
- Animals, Energy Metabolism, Humans, Schizophrenia, Oxidative Stress, Proteome, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review